Slate Path Capital’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $927K | Hold |
|
|||||
|
2024
Q2 | $823K | Hold |
|
|||||
|
2024
Q1 | $1.15M | Hold |
|
|||||
|
2023
Q4 | $1.2M | Hold |
|
|||||
|
2023
Q3 | $1.22M | Hold |
|
|||||
|
2023
Q2 | $1.47M | Hold |
|
|||||
|
2023
Q1 | $3.11M | Hold |
|
|||||
|
2022
Q4 | $4.7M | Hold |
|
|||||
|
2022
Q3 | $6.16M | Hold |
|
|||||
|
2022
Q2 | $3.93M | Hold |
|
|||||
|
2022
Q1 | $7.95M | Hold |
|
|||||
|
2021
Q4 | $12.3M | Hold |
|
|||||
|
2021
Q3 | $22M | Hold |
|
|||||
|
2021
Q2 | $27.9M | Buy |
|
|||||
|
2021
Q1 | $17.3M | Hold |
|
|||||
|
2020
Q4 | $19M | Hold |
|
|||||
|
2020
Q3 | $37.7M | Buy |
|
|||||
|
2020
Q2 | $7.07M | Hold |
|
|||||
|
2020
Q1 | $3.17M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $10.7M | Buy |
|
|||||
|
2019
Q2 | $8.18M | Buy |
|